BioAge Labs, Inc. (BIOA)

Profile

Full Name

BioAge Labs, Inc.

Ticker

NASDAQ: BIOA

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

September 26, 2024

Indexes

Not included

Website

https://bioagelabs.com

Employees

62

Key Details

Price

$5.42(+3.83%)

Market cap

$194.31M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$6.63(-100.00% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.42
    BIOA price is $5.42

    30-Day Relative Volume

    0.76
    BIOA 30-day relative volume is 0.76

    Price Performance

    Price Most recent change

    +3.83%
    BIOA price was up +3.83% on Sep 26, 2025

    Price YTD change

    -6.39%
    BIOA price is down -6.39% since January 1st

    Price 1-year change

    -70.4%
    BIOA price is down -70.4% year-on-year

    Price 3-year change

    -
    BIOA price 3-year change is unknown

    Price Range

    Price All-time high

    $26.62
    BIOA price is currently -79.64% below its historical high of $26.62

    Price 3-year low

    $2.88
    BIOA price is currently +88.19% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $194.31M
    BIOA market capitalization is $194.31 million

    Market cap 3-year change

    -
    BIOA market capitalization 3-year change is unknown

    Market cap All-time high

    $925.16M
    BIOA market capitalization is currently -79.00% below its historical high of $925.16 million

    Market cap sector rank

    49.75%
    BIOA market capitalization is higher than 49.75% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +4.93%
    BIOA shares outstanding is up +4.93% year-on-year

    Shares Outstanding 3-Year Change

    -
    BIOA shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.75
    BIOA beta is 0.75

    200-day SMA

    $4.49
    BIOA price is currently +20.83% above its 200-day simple moving average

    50-day SMA

    $4.69
    BIOA price is currently +15.47% above its 50-day simple moving average

    RSI

    62.79
    BIOA 14-day relative strength index is 62.79

    Volume

    0.76
    BIOA 30-day relative volume is 0.76

    ATR

    $0.25
    BIOA average true range is $0.25

    10-day Historical Volatility

    65.17%
    BIOA 10-day historical volatility is 65.17%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    BIOA annual revenue is $0.00

    Revenue Analysts estimate

    $5.11M
    BIOA annual revenue is currently -100.00% lower than the consensus analysts' forecast

    Revenue 1-year change

    0%
    BIOA annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.74%
    BIOA annual revenue is higher than 28.74% of companies in Healthcare sector

    EPS

    EPS

    -$6.63
    BIOA annual earnings per share is -$6.63

    EPS Analysts estimate

    -$2.01
    BIOA annual earnings per share is currently +230.25% higher than the consensus analysts' forecast

    EPS 1-year change

    -100%
    BIOA annual earnings per share is down -100% year-on-year

    EPS Sector rank

    16.55%
    BIOA annual earnings per share is higher than 16.55% of companies in Healthcare sector

    Profit

    Gross profit

    -$167.00K
    BIOA annual gross profit is -$167.00 thousand

    Gross margin

    -
    BIOA annual gross profit margin value is unknown

    Operating profit

    -$78.19M
    BIOA annual operating income is -$78.19 million

    Operating margin

    -
    BIOA annual operating profit margin value is unknown

    Net income

    -$71.11M
    BIOA annual net profit is -$71.11 million

    Net margin

    -
    BIOA annual net profit margin value is unknown

    Expenses

    Total expenses

    $78.19M
    BIOA annual total expenses is $78.19 million

    Operating expenses

    $78.19M
    BIOA annual total operating expenses is $78.19 million

    Cost of goods sold

    $167.00K
    BIOA annual cost of goods sold is $167.00 thousand

    Selling, general & administrative expenses

    $19.16M
    BIOA annual SGA is $19.16 million

    Depreciation and amortization

    $167.00K
    BIOA annual depreciation & amortization is $167.00 thousand

    Interest expense

    $2.37M
    BIOA annual interest expense is $2.37 million

    Income tax

    $0.00
    BIOA annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$68.74M
    BIOA annual earnings before interest & taxes is -$68.74 million

    EBITDA

    -$68.58M
    BIOA annual EBITDA is -$68.58 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $358.29M
    BIOA annual total assets is $358.29 million

    Non current assets

    $1.13M
    BIOA annual long term assets is $1.13 million

    Current assets

    $357.10M
    BIOA annual total current assets is $357.10 million

    Cash and cash equivalents

    $354.35M
    BIOA annual cash & cash equivalents is $354.35 million

    Accounts receivable

    -
    BIOA annual accounts receivable value is unknown

    Inventory

    $0.00
    BIOA annual inventory is $0.00

    Liabilities

    Total liabilities

    $35.17M
    BIOA annual total liabilities is $35.17 million

    Long term liabilities

    $7.33M
    BIOA annual total long term liabilities is $7.33 million

    Current liabilities

    $27.77M
    BIOA annual total current liabilities is $27.77 million

    Accounts payable

    $2.00M
    BIOA annual accounts payable is $2.00 million

    Debt

    Total debt

    $8.70M
    BIOA annual total debt is $8.70 million

    Total debt 1-year change

    -75.18%
    BIOA annual total debt is down -75.18% year-on-year

    Long term debt

    $2.50M
    BIOA annual long term debt is $2.50 million

    Short term debt

    $6.20M
    BIOA annual short term debt is $6.20 million

    Equity & Capital

    Shareholders equity

    $323.13M
    BIOA annual stockholders equity is $323.13 million

    Book value

    $323.13M
    BIOA annual book value is $323.13 million

    Retained earnings

    -$252.81M
    BIOA annual retained earnings is -$252.81 million

    Working capital

    $329.33M
    BIOA annual working capital is $329.33 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$51.52M
    BIOA annual cash flow from operations is -$51.52 million

    Cash from operations 1-year change

    -37.9%
    BIOA annual cash flow from operations is down -37.9% year-on-year

    Cash from investing

    -$366.00K
    BIOA annual cash flow from investing activities is -$366.00 thousand

    Cash from investing 1-year change

    -37.59%
    BIOA annual cash flow from investing activities is down -37.59% year-on-year

    Cash from financing

    $381.20M
    BIOA annual cash flow from financing activities is $381.20 million

    Cash from financing 1-year change

    +990.98%
    BIOA annual cash flow from financing activities is up +990.98% year-on-year

    CAPEX

    CAPEX

    $366.00K
    BIOA annual capital expenditures is $366.00 thousand

    CAPEX 1-year change

    +120.48%
    BIOA annual capital expenditures is up +120.48% year-on-year

    Free Cash Flow

    Free cash flow

    -$51.89M
    BIOA annual free cash flow is -$51.89 million

    Free cash flow 1-year change

    -38.26%
    BIOA annual free cash flow is down -38.26% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    BIOA annual gross profit margin value is unknown

    Operating margin

    -
    BIOA annual operating profit margin value is unknown

    Net margin

    -
    BIOA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -37.01%
    BIOA annual return on assets is -37.01%

    ROE

    -50.35%
    BIOA annual return on equity is -50.35%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BIOA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BIOA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.66
    BIOA price to book ratio is 0.66

    PB ratio Sector rank

    27.55%
    BIOA price to book ratio is higher than 27.55% of companies in Healthcare sector

    PS Ratio

    PS ratio

    50.30
    BIOA price to sales ratio is 50.30

    PS ratio Sector rank

    87.24%
    BIOA price to sales ratio is higher than 87.24% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    -$94.24M
    BIOA enterprise value is -$94.24 million

    Enterprise value Sector rank

    0.76%
    BIOA enterprise value is higher than 0.76% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    1.21
    BIOA EV/EBITDA is 1.21

    EV/EBITDA Sector rank

    74.33%
    BIOA EV/EBITDA is higher than 74.33% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    12.86
    BIOA annual current ratio is 12.86

    Quick ratio

    12.86
    BIOA annual quick ratio is 12.86

    Leverage

    Debt to equity

    0.03
    BIOA annual debt to equity ratio is 0.03

    Interest coverage ratio

    -29.04
    BIOA annual interest coverage ratio is -29.04

    Risk & Stability

    Piotroski F-Score

    -
    BIOA piotroski f-score value is unknown

    Altman Z-Score

    2.80
    BIOA altman z-score is 2.80

    Analyst ratings

    Recent major analysts updates

    Mar 24, 25 Citigroup
    Neutral
    Feb 28, 25 William Blair
    Market Perform
    Dec 9, 24 Jefferies
    Hold
    Dec 9, 24 Citigroup
    Neutral

    Institutional Ownership

    Screeners with BIOA included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Stocks recommended to hold
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    Stocks above analysts price target
    • What is the ticker symbol for BioAge Labs, Inc.?
    • Does BioAge Labs, Inc. pay dividends?
    • What sector is BioAge Labs, Inc. in?
    • What industry is BioAge Labs, Inc. in?
    • What country is BioAge Labs, Inc. based in?
    • When did BioAge Labs, Inc. go public?
    • Is BioAge Labs, Inc. in the S&P 500?
    • Is BioAge Labs, Inc. in the NASDAQ 100?
    • Is BioAge Labs, Inc. in the Dow Jones?
    • When was BioAge Labs, Inc.'s last earnings report?
    • When does BioAge Labs, Inc. report earnings?

    What is the ticker symbol for BioAge Labs, Inc.?

    The ticker symbol for BioAge Labs, Inc. is NASDAQ:BIOA

    Does BioAge Labs, Inc. pay dividends?

    No, BioAge Labs, Inc. does not pay dividends

    What sector is BioAge Labs, Inc. in?

    BioAge Labs, Inc. is in the Healthcare sector

    What industry is BioAge Labs, Inc. in?

    BioAge Labs, Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is BioAge Labs, Inc. based in?

    BioAge Labs, Inc. is headquartered in United States

    When did BioAge Labs, Inc. go public?

    BioAge Labs, Inc.'s initial public offering (IPO) was on September 26, 2024

    Is BioAge Labs, Inc. in the S&P 500?

    No, BioAge Labs, Inc. is not included in the S&P 500 index

    Is BioAge Labs, Inc. in the NASDAQ 100?

    No, BioAge Labs, Inc. is not included in the NASDAQ 100 index

    Is BioAge Labs, Inc. in the Dow Jones?

    No, BioAge Labs, Inc. is not included in the Dow Jones index

    When was BioAge Labs, Inc.'s last earnings report?

    BioAge Labs, Inc.'s most recent earnings report was on August 6, 2025

    When does BioAge Labs, Inc. report earnings?

    The next expected earnings date for BioAge Labs, Inc. is November 6, 2025
    On this page